AJP - Endo Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 297: E392-E401, 2009. First published May 26, 2009; doi:10.1152/ajpendo.90529.2008
0193-1849/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figures and Tables
Right arrow All Versions of this Article:
297/2/E392    most recent
90529.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Ramamoorthy, S.
Right arrow Articles by Buck, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramamoorthy, S.
Right arrow Articles by Buck, M.

Decreased Jun-D and myogenin expression in muscle wasting of human cachexia

Sonia Ramamoorthy,1,2 Michael Donohue,4,5 and Martina Buck2,3,6

1Department of Surgery, 2Department of Medicine, 3Moores Cancer Center, 4General Clinical Research Center, and 5Biostatistics and Bioinformatics, University of California San Diego; and 6Veterans Affairs Healthcare System, San Diego, California

Submitted 22 June 2008 ; accepted in final form 17 May 2009

Muscle wasting is a critical feature of patients afflicted by acquired immune deficiency syndrome (AIDS), cancer, or chronic inflammatory diseases. In a mouse model of muscle wasting, TNF-{alpha} induces oxidative stress and nitric oxide synthase-2 (NOS2) and decreases myogenin, Jun-D, and creatinine kinase muscle isoform (CKM) expression. Here, we studied 12 patients with muscle wasting due to cancer (N = 10) or AIDS (N = 2) and 4 control subjects. We show that in skeletal muscle of cachectic patients there is 1) increased expression and activity of the TNF-{alpha} signaling, including TNF-{alpha} mRNA, activation of TNFR1, and TNF-{alpha}-associated to TNFR1; 2) increased oxidative stress, as determined by the presence of malondialdehyde-lysine adducts; 3) increased NOS2 mRNA and protein; 4) decreased expression of Jun-D, myogenin, myosin, and CKM mRNA and protein; 5) impaired CKM-E box binding activities, associated with decreased Jun-D/myogenin activities; and 6) oxidative modification and ubiquitination of Jun-D. These studies show that these molecular pathways are modulated in association with muscle wasting in patients with cancer or AIDS, and whether or not they cause muscle wasting remains to be determined.

muscle atrophy; creatinine kinase; nitric oxide synthase-2; Ref-1



Address for reprint requests and other correspondence: M. Buck, VAMC, 9-111-D, 3350 La Jolla Village Dr., San Diego, CA 92161 (e-mail: mbuck{at}ucsd.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. Sundaram, Z. Pang, M. Miao, L. Yu, and S. S. Wing
USP19-deubiquitinating enzyme regulates levels of major myofibrillar proteins in L6 muscle cells
Am J Physiol Endocrinol Metab, December 1, 2009; 297(6): E1283 - E1290.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.